Jim Tananbaum: Investor, Entrepreneur and Healthcare Innovator

Overview

Jim Tananbaum, founder and CEO of Foresite Capital Management, is widely recognized as an innovator in healthcare and has over 25 years of experience in the field, being recently featured on Forbes’ Midas list of the Top 100 Investors. He and Foresite are currently most highly invested in Intarcia, a twice-yearly implant for those with Type II diabetes that helps control their diabetes and promotes weight loss.

In a recent interview with Ideamensch., Jim Tanabaum discusses the inspiration for Foresite, which he describes as a desire, “to truly understand and harness healthcare’s future.” He also gives an inside look on how he brings his idea to life, as well as describing his daily routine, stressing particularly the importance of balancing family life with meetings and portfolio discussions.

Later in the interview, Jim Tanabaum explains the two most important things he has learned from his experience in the field: how to read the ever-changing trends in healthcare, which he calls reading, “where the puck is going,” and learning to trust his instincts on what will optimize business growth rather than doing things the way they have always been done. Check out Forbes for more info.

Professional Career

Tananbaum possesses a Master’s Degree in Science from MIT, as well as an MD from Harvard Medical School and and MBA from Harvard Business school. In 1991, he co-founded and worked as CEO of GelTex, later bought by Genzyme, and he then worked as a partner at Sierra Ventures from 1993-1997. Tananbaum also co-founded Theravance in 1997, acting as Chief Executive Officer until 2000. From 2001-2010, Jim worked as Managing Director of Prospect Venture Partners II and III, which he co-founded. Since 2010, he has acted as CEO of Foresite, which he founded. Tananbaum’s major investments have included Amira Pharmaceuticals, Amerigroup, Healtheon and Jazz Pharmaceuticals. His dedication and investment and management skills have led him to be recognized by publications such as Forbes, and widely respected by the healthcare and investment fields.

Check out his website officialjimtananbaum.com

 

Read more: http://www.fiercebiotech.com/venture-capital/foresite-capital-reloads-a-450m-biotech-venture-fund